These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
724 related articles for article (PubMed ID: 33735106)
1. Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19. Zhang W; Gao Y; Hu G; Chu Q; Yuan X Aging (Albany NY); 2021 Mar; 13(6):7733-7744. PubMed ID: 33735106 [TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19. Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503 [TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study. Cui N; Yan R; Qin C; Zhao J Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277 [TBL] [Abstract][Full Text] [Related]
4. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study. Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19. Ni M; Tian FB; Xiang DD; Yu B J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153 [TBL] [Abstract][Full Text] [Related]
6. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients. Jiang N; Li Z; Yang B; Jin M; Sun Y; He Y; Liu Y; Wang Y; Si D; Ma P; Zhang J; Liu T; Yu Q Biomed Res Int; 2021; 2021():9101082. PubMed ID: 33542929 [TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study. Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P Front Immunol; 2021; 12():581469. PubMed ID: 33664741 [No Abstract] [Full Text] [Related]
8. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19. Li Q; Xu W; Li WX; Huang CL; Chen L Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774 [TBL] [Abstract][Full Text] [Related]
10. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study. Gan J; Li J; Li S; Yang C Front Public Health; 2020; 8():299. PubMed ID: 32626680 [No Abstract] [Full Text] [Related]
11. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection. Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797 [TBL] [Abstract][Full Text] [Related]
12. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027 [TBL] [Abstract][Full Text] [Related]
13. Elevated Exhaustion Levels of NK and CD8 Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D Front Immunol; 2020; 11():580237. PubMed ID: 33154753 [TBL] [Abstract][Full Text] [Related]
14. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19. Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X Front Immunol; 2021; 12():626235. PubMed ID: 33584733 [TBL] [Abstract][Full Text] [Related]
15. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19. Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221 [TBL] [Abstract][Full Text] [Related]
16. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. Wang Z; Wang Z BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706 [TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological features of severe and moderate coronavirus disease 2019. Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835 [TBL] [Abstract][Full Text] [Related]
19. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study. Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583 [TBL] [Abstract][Full Text] [Related]
20. Immunological alternation in COVID-19 patients with cancer and its implications on mortality. Cai G; Gao Y; Zeng S; Yu Y; Liu X; Liu D; Wang Y; Yu R; Desai A; Li C; Gao Q Oncoimmunology; 2021 Jan; 10(1):1854424. PubMed ID: 33489469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]